【结 构 式】 |
【分子编号】66719 【品名】(R)-1-(benzyloxy)-4-(2,4,5-trifluorobenzyl)azetidin-2-one 【CA登记号】 |
【 分 子 式 】C17H14F3NO2 【 分 子 量 】321.29891 【元素组成】C 63.55% H 4.39% F 17.74% N 4.36% O 9.96% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(IX)
【1】 Hansen KB, Balsells J. Dreher S et a1. 2005. First Generation Process for the Preparation of the DPP-IV Inhibitor Sitagliptin. Org Proc Rea.Dev.,9(5): 634~639. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 24075 | 2-chloropyrazine | 14508-49-7 | C4H3ClN2 | 详情 | 详情 |
(II) | 66713 | 2-Hydrazinopyrazine | 54608-52-5 | C4H6N4 | 详情 | 详情 |
(III) | 66714 | C8H4F6N4O2 | 详情 | 详情 | ||
(IV) | 66715 | 3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyrazine | C6H3F3N4 | 详情 | 详情 | |
(V) | 66705 | 3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride | 486460-21-3 | C6H7F3N4.HCl | 详情 | 详情 |
(VI) | 66716 | methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate | 769195-26-8 | C11H9F3O3 | 详情 | 详情 |
(VII) | 66717 | (R)-3-hydroxy-4-(2,4,5-trifluorophenyl)butanoic acid | C10H9F3O3 | 详情 | 详情 | |
(VIII) | 66718 | (R)-N-(benzyloxy)-3-hydroxy-4-(2,4,5-trifluorophenyl)butanamide | C17H16F3NO3 | 详情 | 详情 | |
(IX) | 66719 | (R)-1-(benzyloxy)-4-(2,4,5-trifluorobenzyl)azetidin-2-one | C17H14F3NO2 | 详情 | 详情 | |
(X) | 66720 | (R)-3-((benzyloxy)amino)-4-(2,4,5-trifluorophenyl)butanoic acid | C17H16F3NO3 | 详情 | 详情 | |
(XI) | 66721 | (R)-3-((benzyloxy)amino)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one | C23H21F6N5O2 | 详情 | 详情 | |
(XII) | 66722 | (R)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one | 486460-32-6 | C16H15F6N5O | 详情 | 详情 |
Extended Information